Bruker Corporation (NASDAQ:BRKR) Receives $56.79 Average Price Target from Analysts

Posted by Brenda Bartman on Jul 29th, 2026

Bruker Corporation (NASDAQ:BRKR – Get Free Report) has been given a consensus rating of “Hold” by the sixteen analysts that are presently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $56.7857.

Several research firms have commented on BRKR. Barclays upped their price target on Bruker from $53.00 to $60.00 and gave the company an “overweight” rating in a report on Wednesday, June 24th. Citigroup lifted their price objective on Bruker from $44.00 to $60.00 and gave the stock a “neutral” rating in a report on Wednesday, July 8th. Leerink Partners boosted their price objective on Bruker from $60.00 to $70.00 and gave the company an “outperform” rating in a research report on Tuesday, July 7th. Guggenheim upped their target price on Bruker from $50.00 to $70.00 and gave the company a “buy” rating in a research note on Monday, June 29th. Finally, UBS Group set a $60.00 target price on Bruker in a research report on Wednesday, June 24th.

View Our Latest Report on Bruker

Institutional Trading of Bruker

Institutional investors have recently made changes to their positions in the business. Handelsbanken Fonder AB increased its stake in Bruker by 49.6% in the second quarter. Handelsbanken Fonder AB now owns 54,805 shares of the medical research company’s stock valued at $3,298,000 after acquiring an additional 18,165 shares during the period. FNY Investment Advisers LLC bought a new position in Bruker during the second quarter worth about $60,000. GAMMA Investing LLC lifted its stake in Bruker by 21.4% during the second quarter. GAMMA Investing LLC now owns 4,755 shares of the medical research company’s stock worth $286,000 after purchasing an additional 839 shares during the period. NewEdge Advisors LLC boosted its holdings in Bruker by 5,291.2% during the first quarter. NewEdge Advisors LLC now owns 1,833 shares of the medical research company’s stock valued at $66,000 after purchasing an additional 1,799 shares in the last quarter. Finally, Essential Partners LLC acquired a new stake in Bruker during the first quarter valued at approximately $36,000. 79.52% of the stock is currently owned by institutional investors and hedge funds.

Bruker Stock Up 4.8%

Shares of BRKR opened at $62.91 on Friday. The company has a 50-day simple moving average of $57.07 and a 200-day simple moving average of $46.41. The firm has a market capitalization of $9.58 billion, a P/E ratio of -262.12, a P/E/G ratio of 1.92 and a beta of 1.29. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.72 and a current ratio of 1.55. Bruker has a 52 week low of $28.53 and a 52 week high of $64.54.

Bruker (NASDAQ:BRKR – Get Free Report) last released its earnings results on Wednesday, May 6th. The medical research company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.08. Bruker had a negative net margin of 0.65% and a positive return on equity of 11.60%. The business had revenue of $823.40 million during the quarter, compared to analysts’ expectations of $795.62 million. During the same quarter last year, the company earned $0.47 earnings per share. The firm’s revenue was up 2.7% on a year-over-year basis. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. On average, equities research analysts expect that Bruker will post 2.12 earnings per share for the current year.

Bruker Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, July 7th. Stockholders of record on Monday, June 22nd were paid a $0.05 dividend. The ex-dividend date was Monday, June 22nd. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.3%. Bruker’s dividend payout ratio is currently -83.33%.

Bruker Company Profile

(Get Free Report)

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.